Skip to content Skip to sidebar Skip to footer

Newsletter

Mid Cap Stocks

Monash IVF (ASX:MVF): Just when you thought a difficult 5 year span was over…

In the decade since fertility provider Monash IVF (ASX:MVF) listed, it was not an easy journey. Only a few months ago, we thought the business had turned a corner and many others did too. Then...trouble struck. Is this a buy the dip opportunity, or a risk of catching a falling knife? Introduction to Monash IVF Monash…

ByNick SundichJune 10, 2025

How to stop the ASX decline? ASIC and investors have some radical ideas

Addressing the ASX decline is a question that has been considered for many months now. In 2023-24, more companies left the ASX in the past 2 years than any 2 year period since the 1990s recession - whether being brought out by private equity or a big industry player, delisting to a penny stock exchange…

ByNick SundichJune 6, 2025

Red Mountain Mining (ASX:RMX) and a critical silvery metal called antimony

Here's something to try out at this weekend's BBQ with the other guests: How much do you know about a metal called antimony? The answer is likely to be next to nothing. Indeed, you might have to explain that the word is pronounced with an emphasis on the first syllable, as in 'AN-ti-muh-nee', and not pronounced…

ByStuart RobertsJune 4, 2025

Battery Age Minerals (ASX:BM8) hopes for a Golden Age from one of the biggest sources of Kerry Packer’s wealth

Last November, our colleagues at Pitt Street Research introduced you to Battery Age Minerals (ASX:BM8), whose potential company-maker is an old lead-zinc mine in Austria called Bleiberg. A re-cap of Bleiberg This project, if it works, will win big for Battery Age shareholders. The mine has been around since the Middle Ages, but the company's advisers…

ByStuart RobertsMay 30, 2025

Proteomics’ PromarkerD test for DKD has been launched in Australia, and two more tests will launch later in 2025

2025 has been, and will continue to be, a big year for Proteomics, which has just launched PromarkerD onto the Australian market. Before this year is over, the company anticipates launching another 2 tests - PromarkerEndo and PromarkerEso; and is eyeing off the US market too. Recap of Proteomics (ASX:PIQ) For investors that are new to…

ByNick SundichMay 28, 2025

Catapult Group (ASX:CAT): Making fistfuls of dollars from the world’s elite sporting clubs

Sport is becoming more and more of a big business and the existence and success of Catapult Group (ASX:CAT) is a testament to that. It works with over 4,400 elite teams in over 100 countries across several different codes. These include the Philadelphia Eagles and Kansas City Chiefs that have faced off in 2 of the…

ByNick SundichMay 26, 2025

Nufarm (ASX:NUF): Hit by lower commodity prices, adverse weather and Trump’s tariffs

Have some sympathy for Nufarm (ASX:NUF). Companies capped at over $1bn rarely plunge 30% after reporting results unless the results (or the outlook) were bad enough to warrant it, and this is just what happened earlier this week. Introduction to Nufarm (ASX:NUF) Nufarm is an agricultural chemical supplier and manufacturer - its most important is omega-3…

ByNick SundichMay 23, 2025

This Time is Different: John Templeton said this phrase was costly in 1933, but here is when it may be true

'The investor who says, "This time is different," when in fact it’s virtually a repeat of an earlier situation, has uttered among the four most costly words in the annals of investing'. This quote was said by John Templeton’s in his work '16 rules for Investment Success'. Why Templeton thought 'This Time is Different' was…

ByNick SundichMay 21, 2025

Investors are excited about Core Lithium’s planned re-start of Finniss! But here’s why they’re overreacting

Core Lithium's (ASX:CXO) planned re-start of Finniss has got plenty of investors excited. Shares closed yesterday 35% higher than the day before, making the company one of the biggest gainers on the bourse. This is not just because investors in this company can see light at the end of the tunnel, but it bodes hope…

ByNick SundichMay 15, 2025

Gorilla Gold Mines (ASX:GG8): Its skyrocketed from a minnow to a $300m company

Gorilla Gold Mines (ASX:GG8) has had a run in 12 months that its shareholders could only have dreamed of. The company wasn't even known as Gorilla Gold Mines a year ago. It was called Labyrinth Resources, so-called after one of two projects in Canada it held and would sell in early 2024 for a paltry US$3.5m.…

ByNick SundichMay 14, 2025

the Kick-ass Multipurpose WordPress Theme

Mid Cap Stocks

Monash IVF (ASX:MVF): Just when you thought a difficult 5 year span was over…

How to stop the ASX decline? ASIC and investors have some radical ideas

Red Mountain Mining (ASX:RMX) and a critical silvery metal called antimony

Battery Age Minerals (ASX:BM8) hopes for a Golden Age from one of the biggest sources of Kerry Packer’s wealth

Proteomics’ PromarkerD test for DKD has been launched in Australia, and two more tests will launch later in 2025

Catapult Group (ASX:CAT): Making fistfuls of dollars from the world’s elite sporting clubs

Nufarm (ASX:NUF): Hit by lower commodity prices, adverse weather and Trump’s tariffs

This Time is Different: John Templeton said this phrase was costly in 1933, but here is when it may be true

Investors are excited about Core Lithium’s planned re-start of Finniss! But here’s why they’re overreacting

Gorilla Gold Mines (ASX:GG8): Its skyrocketed from a minnow to a $300m company

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Mid Cap Stocks

Stocks in Spotlight

Add Your Heading Text Here